CMN Weekly (9 February 2024) - Your Weekly CRISPR Medicine News

Some of the best links we picked up around the internet

By: Gorm Palmgren - Feb. 9, 2024
News

#CRISPRMED24

Top picks

Research

Industry

Detection

CRISPR screens

Reviews

News from CRISPR Medicine News

  • Monday, we brought a transcript of our first CMN Live event broadcast last Friday. Our editor-in-chief, Karen O'Hanlon Cohrt, spoke with Dr Eric Kmiec, the Scientific Director at the ChristianaCare Gene Editing Institute in Delaware and Chief Scientific Officer at CorriXR Therapeutics. They discussed the successes of therapeutic gene editing to date and the challenges that lie ahead. You can watch the interview on LinkedIn here.

To get more of the CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN Weekly

News: CMN Weekly (9 February 2024) - Your Weekly CRISPR Medicine News
News: CMN Weekly (9 February 2024) - Your Weekly CRISPR Medicine News
CLINICAL TRIALS
Renal Cell Carcinoma, RCC, (NCT06245915)
Sponsors:
Arsenal Biosciences, Inc.
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Solid Tumors, (NCT06237881)
Sponsors:
M.D. Anderson Cancer Center
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Breast Cancer, BC, (NCT05812326)
Sponsors:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine